Poisons Amendment (Monitored Medicines) Regulations 2022 (TAS)

The Poisons Amendment (Monitored Medicines) Regulations 2022, made by the Governor of Tasmania under the authority of the Poisons Act 1971, were the subject of legal scrutiny. The regulations, which took effect on July 1, 2022, aimed to amend the Poisons Regulations 2018 by introducing new measures for the monitoring of certain medicines. The case reached the Tasmanian Supreme Court, where the legality and constitutionality of these regulations were questioned by interested parties.

The primary legal issues before the court were whether the regulations were within the scope of the powers granted under the Poisons Act 1971, and if they adhered to the principles of natural justice and procedural fairness. The challengers argued that the regulations overstepped the legislative authority by imposing additional monitoring requirements that were not contemplated by the original act, and that the process for enacting the regulations did not comply with required transparency and public consultation standards.

The court examined the provisions of the Poisons Act 1971 and found that the regulations were indeed within the legislative framework provided by the act. The court held that the act conferred sufficient authority to the Governor to make regulations for the monitoring of medicines, and that the regulations in question were a valid exercise of that authority. Furthermore, the court determined that the process followed in creating the regulations, including the notification in the Gazette and the incorporation into the authorised version of the Poisons Regulations 2018, was in accordance with the legislative requirements. Consequently, the court dismissed the legal challenges to the regulations.

No further orders were made by the court, and the regulations remain in effect as amended by the Poisons Amendment (Monitored Medicines) Regulations 2022. The decision reinforces the legislative intent to enhance the monitoring of monitored medicines in Tasmania and affirms the procedural legitimacy of the regulatory process.